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Abstract
Background: Gardnerella vaginalis is a facultative gram positive organism that requires subculture
every 1–2 days to maintain viability. It has been linked with bacterial vaginosis (BV), a syndrome
that has been associated with increased risk for preterm delivery, pelvic inflammatory disease and
HIV acquisition. About 10% of the G. vaginalis isolates have been reported to produce sialidase, but
there have not been any studies relating sialidase production and biotype. Sialidase activity is
dramatically increased in the vaginal fluid of women with BV and bacterial sialidases have been
shown to increase the infectivity of HIV in vitro. There are 8 different biotypes of G. vaginalis.
Biotypes 1–4 produce lipase and were reported to be associated with BV and the association of
these biotypes with BV is under dispute. Other studies have demonstrated that G. vaginalis biotype
1 can stimulate HIV-1 production. Because of the discrepancies in the literature we compared the
methods used to biotype G. vaginalis and investigated the relationship of biotype and sialidase
production.
Results: A new medium for maintenance of Gardnerella vaginalis which allows survival for longer
than one week is described. Some isolates only grew well under anaerobic conditions. Sialidase
producing isolates were observed in 5 of the 6 biotypes tested. Using 4-methylumbelliferyl-oleate
to determine lipase activity, instead of egg yolk agar, resulted in erroneous biotypes and does not
provide reliable results.
Conclusion:  Previous studies associating G. vaginalis biotype with bacterial vaginosis were
methodologically flawed, suggesting there is not an association of G. vaginalis biotypes and bacterial
vaginosis. Sialidase activity was observed in 5 of the 8 biotypes.
Background
Bacterial vaginosis (BV) is one of the most common rea-
sons for women to seek medical attention; the underlying
cause of BV is controversial. Women with BV are at higher
risk for preterm delivery, pelvic inflammatory disease
(PID) and acquisition of HIV [1-5]. Several reports have
demonstrated that women with BV have elevated levels of
sialidase activity [6-9], although the source has not been
demonstrated. Studies have demonstrated that treatment
of HIV-1 or lymphocytes with bacterial sialidase increases
the infectivity of the virus [10,11]. A number of different
bacteria have been associated with BV, including Gard-
nerella vaginalis [12-14]. G. vaginalis can be isolated from
women without any symptoms and recovered from sites
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which are usually sterile [15,16]. Studies have also shown
G. vaginalis biotype 1 fractions are capable of stimulating
HIV-1 production [17]. G. vaginalis is a fastidious organ-
ism requiring subculture to fresh media every two days.
Isolates identified as G. vaginalis may be further character-
ized by β-galactosidase and lipase activity and hippurate
hydrolysis resulting in 8 biotypes [18]. According to one
study biotypes 1–4 produce lipase and in a longitudinal
study were significantly associated with BV. After success-
ful treatment, the predominant G. vaginalis biotypes
shifted to non-lipase producing types 5–8 [6]. Other stud-
ies did not find a relationship between BV and biotype or
genotype [15]. Piot et al. [18] defined biotypes using egg
yolk agar (EY) to test for lipase while Briseldon and Hillier
[6] used 4-methylumbelliferyl-oleate (MUO). Since the
use of MUO had not been validated, we compared the
results of lipase detection using egg yolk to those obtained
with MUO. Because G. vaginalis sialidase could play an
important role in both BV and HIV infection we also
tested our strains for sialidase activity.
Methods
Gardnerella vaginalis agar (GVA)
Most of our work is performed with strains with a low
number of passages; we therefore devised a medium for G.
vaginalis  that facilitated our work by not requiring fre-
quent subculture to fresh medium. GVA was prepared by
dissolving: Brain Heart Infusion 37 g, Bacto-Tryptone 5 g,
yeast extract 1 g, soluble starch 1 g, KH2PO4 6.8 g, and L-
cysteine HCl 0.3 g in 1 liter of distilled water. The pH was
then adjusted to 7.2 with sodium hydroxide and Bacto-
agar added to a final concentration 1.5% and the medium
sterilized by autoclaving. The medium was cooled and
dispensed to 100 mm plastic Petri plates, then air dried for
30 min and stored at 4°C. To analyze the survival on GVA
the G. vaginalis isolates were cultured from blood agar
plates (BAP) onto GVA plates on the first day. Subcultures
were made from the first day GVA plates onto a fresh BAP
and GVA daily for one week or until the subcultures failed
to grow.
Bacteria
The reference strain of G. vaginalis, ATCC 14018, was
obtained from the American Type Culture Collection.
Human vaginal isolates of G. vaginalis were kindly pro-
vided by Lorna Rabe, (Magee Womens Research Institute,
Pittsburgh PA). Initial identifications were based on col-
ony morphology, Gram stain, lack of catalase activity and
hemolysis on human bilayer tween medium (HBT) but
not sheep blood agar. Isolates were stored frozen at -80°C
until needed, then revived and maintained on Columbia
blood agar containing 5% sheep's blood PML Microbio-
logicals (PML Microbiologicals, Wilsonville, OR.).
Biotyping
β-galactosidase, lipase activity and hippurate hydrolysis
were performed as described previously [18]. Egg yolk
agar plates for lipase reactions were obtained from PML
Microbiologicals (PML Microbiologicals, Wilsonville,
OR.) were inoculated and examined daily for 7 days. The
presence of an oily sheen on and surrounding the bacte-
rial growth was interpreted as a positive result for lipase
activity. Staphylococcus aureus and Pseudomonas aeruginosa
were used as positive controls, Lactobacillus crispatus was
used as a negative control.
Lipase activity using 4-methylumbelliferyl-oleate
Lipase activity was also determined as described by
Briselden and Hillier [6], using 4-methylumbelliferyl-
oleate (Fluka 75164, from the Sigma Aldrich Chemical
Co., St. Louis, MO.) using a spot test as previously
described [6,19]. Briefly, MUO was dissolved in absolute
ethanol to a concentration of 4 mg/ml and used to soak a
60 by 6 mm (approximate) Whatman #2 filter paper strip
(Whatman, Inc., Clifton, N.J.). After air drying, strips were
moistened with buffer, phosphate buffered saline or ACES
both pH 7.0 containing 22 mM N-octyl-β-D-glucopyrano-
side, and 12 mM CaCl2. Alternatively, the MUO was sus-
pended in water and mixed with equal parts of 2 fold
concentrated buffer as described above. The strips were
inoculated with a loopful of bacteria, incubated at 35°C,
and read under a long-wavelength (365 nm), hand-held
mineral lamp as described previously [19].
Sialidase activity using 2'(4-methylumbelliferyl) – α-D-N-
acetylneuraminic acid
Sialidase activity was determined as described previously
by Moncla et al. [19] using 4-methylumbelliferyl- α-D-N-
acetylneuraminic acid as substrate (Sigma M8639, from
the Sigma Aldrich Chemical Co., St. Louis, MO.). Stock
solutions of the substrate were prepared by dissolving 1
mg in 6.6 ml distilled water, dispensing into 180 μl vol-
umes and storing at -20°C. The stock solutions were
thawed and 20 μl 1.0 M sodium acetate buffer, pH 4.8
added and mixed in. The resulting solutions were used in
a filter paper strip assay as described above for the 4-meth-
ylumbelliferyl-oleate lipase assay.
Results
All strains survived for 7 days on GVA (Table 1) and by
week three about one third of the strains were viable. We
did not find any isolates representing biotypes 6 and 8.
Several isolates grew little if at all on the GVA or blood
agar aerobically; however, good growth was observed for
all isolates when cultured anaerobically. On EY (see
below), 7 of the isolates failed to grow in air plus 6% CO2
but did grow well anaerobically (Table 1). Strains grown
on GVA gave identical biochemical reactions for β-galac-BMC Microbiology 2009, 9:78 http://www.biomedcentral.com/1471-2180/9/78
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tosidase, sialidase and hippurate hydrolysis as when
grown on BAP.
Lipase activity was detected in 21 of 31 strains tested
(68%) using egg yolk agar but using the MUO spot test
only 12 of 31 strains tested positive (39%) (Table 1). To
assess the performance of the MUO based lipase test, the
egg yolk reactions were used as the true values in the sta-
tistical comparison as described previously by Moncla et
al. [20]. The values obtained for the MUO test were: sen-
sitivity (32%), specificity (33%), positive predictive value
(54%) and negative predictive value (17%). The alternate
method for lipase detection (see above, mixing equal vol-
umes of buffer and liquid substrate) demonstrated a lack
of reproducibility and the results from these assays are not
presented.
Sialidase was detected in one or more strains of biotypes
1, 2, 4, 5 and 7 but not in strains from biotype 3, (Table
1). Biotypes 6 and 8 were not found among the strains
examined. Most of the strains studied were biotype 1
(32.2%), followed by biotypes 2, 7, 4, 5, and 3 (22.5%,
19.5%, 9.6%, 9.6%, 6.5% respectively). Overall, the 39%
of the strains tested demonstrated sialidase activity.
Table 1: Characteristics of Gardnerella vaginalis isolates on GVA: Biotypes, strain designations, growth and enzymatic activities
Isolate designa-
tion (Biotype)A
48 hr growth 
GVA plates
Viability at 7 
days On GVA 
platesB
Aerobic Growth 
on EY
Lipase Egg yolkC Lipase with 4-
MUO
Sialidase
0284 (1) + + + + - +
0287 (1) + + + + - +
0828E (1) + + + + - -
0377 (1) + + + + - -
ATCC 14018 (1) + + + + - -
C31g 7571–2 (1) + + + + - -
I T P ( 1 ) ++++- -
PID 0286E (1) + + + + + +
UPS 1388E (1) + + - + + -
UPS1492 (1) + + + + - +
5 5 1 ( 2 ) ++++- -
UPS1476 (2) + + + + + -
HPTN
208000837 (2) + + + + - +
UC781 64/20- 
LITTLE
( 2 ) +++++ +
UC781 64/20- BIG (2) + + + + + +
UP548 (2) + + - + - +
UPS 754 (2) + + + + - -
055/15 (3) + + + + + -
UP537 E (3) + + + + - -
RING52576 (4) + + + + + -
HPTN 213000700 (4) + + + + - +
UPS 1400E (4) -/scantD +++- -
UPS 1398Ea (5) + + - - - +
UPS 1483E (5) - + - - + -
UPS 1500E (5) + + - - - -
061/19 V5 (7) + + + - + +
HPTN008 000750 (7) - + - - + -
Up 582 (7) + + + - + -
UPS 1401 E (7) + + + - + +
UPS 2050E (7) + + + - - -
UPS1475 (7) + + - - + -
AThe biotype of each isolate is given in parentheses.
BTo accommodate those isolates demonstrating better growth anaerobically all strains were incubated in anaerobe jars. Aerobic organisms 
survived equally well under either incubation condition. Cultures were considered viable after 7 days if they were successfully subcultured to fresh 
GVA and blood agar plates.
CAll strains were tested for lipase production on egg yolk agar under aerobic and anaerobic conditions; strains demonstrating growth aerobically 
yield identical lipase reaction when grown anaerobically. When strains did not grow aerobically on egg yolk plates the reactions indicated are taken 
from anaerobic incubation. Lipase reactions using 4-methylumbelliferone-oleate are given in parentheses.
DSome organisms demonstrated poor growth when incubated in air plus 6% CO2, these organisms all had excellent growth on GVA plates after 
anaerobic incubation.BMC Microbiology 2009, 9:78 http://www.biomedcentral.com/1471-2180/9/78
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Discussion
GVA provides an inexpensive alternative to the long term
cultivation of G. vaginalis, compared to blood agar or HBT
on which the organism requires passage every day or two.
Some isolates survived for up to three weeks on the GVA.
HBT is an important medium commonly used to test the
hemolysis characteristics and to maintain the organism;
however, it is too expensive for long term passage of the
organism.
Sialidase activity is an important feature in bacterial vagi-
nosis. Accordingly, we concurrently tested our strains for
the enzyme. Previous reports had noted the enzyme in
10% of the isolates [21]. We observed higher rates among
our isolates 39% (table 1). About one third of our isolates
were biotype 1, of which 40% of the isolates were positive.
The presence of sialidase was detected in strains from all
biotypes tested except biotype 3; however, we only had
three isolates identified as biotype 3. We did not identify
any isolates as biotypes 6 or 8.
The sialidase activity associated with BV is most likely
from bacterial sources, although the specific organisms
have not been identified. We report a higher incidence of
the enzyme than reported by others [21] the significance
is difficult to access since we only examined 31 strains.
Because they are found in low frequency we did not test
biotype 6 or 8. Other bacteria associated with BV have a
much greater percentage of isolates that produce sialidase
for example; all isolates of Prevotella bivia produced the
enzyme [19]. While P. bivia isolates all produce sialidase,
only about 3% of the activity is released into the medium;
however, we do observe surprisingly large amounts of
sialidase in the culture supernatants of sialidase produc-
ing strains of G vaginalis (Moncla unpublished observa-
tions).
Because of the relationship between G. vaginalis biotype
and the stimulation of HIV replication [12,17]; we
attempted to biotype our strains using the MUO method
of Briselden and Hillier. G. vaginalis ATCC 14018 is bio-
type 1; however because of a negative lipase reaction we
consistently identified it as biotype 6. As the MUO
method of Briselden and Hillier had not been validated
we compared the results of lipase detection using egg yolk
agar to those obtained with MUO. The choice of lipase
substrate had a dramatic effect on the biotype. For exam-
ple, using EY lipase results there are 10 strains listed in
Table 1 as biotype 1; however, using MUO as the sub-
strate, only 2 of the 10 isolates demonstrated lipase activ-
ity. The 8 strains that were negative using MUO would
have been incorrectly identified as biotype 6. Overall 20
of the tested isolates would have yielded a different bio-
type depending on the method used for testing lipase
activity. The MUO method had poor sensitivity and spe-
cificity when calculated as described previously [20].
Using the EY data for biotyping as presented in Table 1, we
observed a distribution of biotypes that is roughly similar
to that reported by Piot et al.
Lipases are specialized esterases; therefore, which syn-
thetic substrates, if any, are appropriate is controversial.
Studies suggest synthetic substrates such as MUO detect
non-specific esterase activity [22-27]. Our data would sup-
port this concept. When other 4-methylumbelliferyl fatty
acids were used, we observed all strains give a positive test
results with MU-heptonate but none with 4-methylum-
belliferyl palmitic acid, indicating the assays are measur-
ing esterase activity [28,29]. These data would tend to
negate the observations of others regarding the correlation
of G. vaginalis biotype with BV. Briselden and Hillier's
observation of a reduction of lipase producing biotype 1–
4 after successful treatment could be reinterpreted as an
association of non-specific esterase activity in G. vaginalis
with BV [6]. Our results demonstrate the importance of
lipase activity in the typing of G. vaginalis and that lipase
activity should be tested using EY plates or other lipase
assay methods such as titration. Further, our work sug-
gests the reports of biotypes using the MUO or other 4-
methyumbelliferone substrates in lipase spot tests are not
accurate. Other differences exist in the methodologies
reported, Piot et al. and Briselden and Hillier grew cul-
tures anaerobically while the other groups mentioned
grew organisms aerobically with enriched CO2. Lipase
reactions on EY often take up to 7 or more days, and all
these groups used only 3 days or less for reactions. Our
observations suggest all isolates should be cultured anaer-
obically, and EY plates should be incubated for 7 days
before they can be interpreted as lipase negative.
In summary a medium was described that allows survival
of G. vaginalis isolates for at least one week and longer in
some cases. Sialidase activity was observed in 40% of the
strains tested but was not restricted to any particular bio-
types. The synthetic lipase substrate 4-methylumbellif-
eryl-oleate did not reliably detect lipase activity compared
to egg yolk plates.
Conclusion
Our data suggests the relationship of BV and G. vaginalis
biotype should be reexamined, since our study demon-
strates that 4-methylumbelliferyl-oleate and other 4-
methylumbelliferyl- derivatives should not be used for the
detection of lipase activity as a tool for bacterial identifi-
cations. The Gardnerella vaginalis agar allows extended via-
bility of the cultures, therefore the time and costs of
frequent subculture is greatly reduced. We cannot rule out
an association of G. vaginalis, sialidase, BV and increases
in HIV acquisition rates among women with BV.Publish with BioMed Central    and   every 
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